Ameriprise’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.43M	Buy	+102,033	New	+$1.43M	﹤0.01%	3092
2025 Q1	–	Sell	-16,743	Closed	-$341K	–	4015
2024 Q4	$341K	Buy	16,743 +9,343	+126%	+$190K	﹤0.01%	3649
2024 Q3	$216K	Buy	+7,400	New	+$216K	﹤0.01%	3716